Pleura - Mesothelioma

Video

Objective Discrepancies in the MARS-2 Trial: An Interview with David Waller

December 6, 2023 | David Waller…

At the 2023 EACTS Annual Meeting, CTSNet Editor in Chief Joel Dunning and CTSNet senior editors set out to interview the most knowledgeable CT surgeons from around the world. Stay tuned for more interviews from...

Video

Objective Discrepancies in the MARS-2 Trial: An Interview with David Waller

December 6, 2023 | David Waller…

At the 2023 EACTS Annual Meeting, CTSNet Editor in Chief Joel Dunning and CTSNet senior editors set out to interview the most knowledgeable CT surgeons from around the world. Stay...

Video

Laser Assisted Extended Pleurectomy Decortication for Malignant Pleural Mesothelioma

October 25, 2023 | Kudzayi Kutywayo…

Malignant pleural mesothelioma is an aggressive tumor of the pleura. Extended pleurectomy and decortication is a lung sparing cytoreductive procedure used in the management of this disease for curative intent....

JANS Article

Baylor Study: Mesothelioma ‘Staged Surgical Approach’ Increases Survival

January 12, 2023 | Cameron LindSilver Contributor

A recent study found that mesothelioma patients who undergo both lung-sparing extended pleurectomy and decortication can achieve extended survival compared to those who undergo just one type of surgery. When...

JANS Article

In Global News: Prevalence of Spin in RCT Reports, Setting the Standard for Teamwork, and the Continued Public Health Challenge of Asbestos

May 24, 2019 | Claire Vernon

Patient Care and General Interest Despite being the leading cause of death in the US, heart disease was the most-Googled disease in only one state: Maine. A study that sought...

Video

Mesothelioma Debate: The Role of the Surgeon is to Palliate Only

March 16, 2017 | John Butler

Robert Rintoul of Papworth Hospital, Cambridge, UK, reviews the outcomes of major mesothelioma trials, and argues that all mesothelioma surgery is currently palliative. This is part one of a debate...

JANS Article

A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma

September 27, 2016 | Mark FergusonBronze Contributor

Semiautomated CT volumetric measurements of tumor volume in patients with malignant pleural mesothelioma were compared to stage and overall survival. CT volumes correlated well with stage and survival.

...
JANS Article

Prognostic Score of Long-Term Survival After Surgery for Malignant Pleural Mesothelioma: A Multicenter Analysis

September 4, 2015 | Mark FergusonBronze Contributor

This study used a multicenter cohort in Italy to identify prognostic indicators for 3-year survival in patients who had undergone extrapleural pneumonectomy (EPP) for mesothelioma. 23% lived 3 years or...

JANS Article

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

July 30, 2015 | Mark FergusonBronze Contributor

The ESMO Guidelines Committee provides an update to its guidelines for evaluation and management of malignant pleural mesothelioma. They recommend against screening. A biopsy demonstrating tissue invasion is required for...

JANS Article

Effects of Extended Pleurectomy and Decortication on Quality of Life and Pulmonary Function in Patients With Malignant Pleural Mesothelioma

April 30, 2015 | Mark FergusonBronze Contributor

This prospective study evaluated QOL and lung function after extended pleurectomy/decortication (EPD) for mesothelioma in 36 patients. Patients with performance status (PS) 0 experienced little or no improvement in QOL...

JANS Article

Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial

September 25, 2014 | Mark FergusonBronze Contributor

This randomized controlled trial compared VATS partial pleurectomy (VAT-PP) to talc pleurodesis in patients with malignant mesothelioma and a pleural effusion, evaluating overall survival. VAT-PP was associated with significantly greater...

JANS Article

Extrapleural Pneumonectomy in the Treatment of Epithelioid Malignant Pleural Mesothelioma: Novel Prognostic Implications of Combined N1 and N2 Nodal Involvement Based on Experience in 529 Patients

September 16, 2014 | Mark FergusonBronze Contributor

This retrospective review of pts undergoing complete resection by extrapleural pneumonectomy 1998-2011 for malignant mesothelioma focused on stage predictors of survival. Surgical mortality was 5%. Overall survival at 5 years...

JANS Article

Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis

August 11, 2014 | Mark FergusonBronze Contributor

Data from 6 cohort studies were evaluated to assess the ongoing risk of mesothelioma more than 40 years after initial environmental exposure to asbestos. Among over 22,000 of those exposed,...

LOAD MORE
ADVERTISE ON CTSNET